Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST)

Stroke; a Journal of Cerebral Circulation
J L WilterdinkM D Hansen

Abstract

Although the efficacy of aspirin in reducing stroke incidence is clear, its role in reducing stroke severity is disputed. This study compares stroke severity between patients who did or did not take aspirin in the week before stroke and enrollment in the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Of 1275 patients randomized, 509 reported aspirin use in the week before stroke; 766 did not. Clinical stroke severity was assessed with the National Institutes of Health Stroke Scale (NIHSS) and the Supplementary Motor Examination (SME) at trial entry and at 3 months. Using these scales, we compared the categorization of stroke severity (mild, moderate, and severe) and mean scores between aspirin users and nonusers. The difference in distribution of baseline NIHSS scores was statistically significant between aspirin users and nonusers (P=0.006), with a greater percentage of milder strokes among aspirin users. The difference in mean baseline NIHSS scores was also significantly lower in aspirin users (8.2) and nonusers (9.3) (P=0.003). The distribution of baseline SME scores and mean SME scores also showed lower stroke severity in aspirin users than in nonusers (P=0.048 and P=0.004, respectively). At 3 months, differences in ...Continue Reading

References

Jun 10, 2003·Current Atherosclerosis Reports·Kiat T TanAndrew D Blann
Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jens Minnerup, Wolf-Rüdiger Schäbitz
Sep 23, 2006·The Neurologist·Geysu KarlikayaHülya Tireli
Mar 30, 2005·Clinical Neuropharmacology·Yair LamplMenachem Sadeh
Dec 17, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y S KimB-W Yoon
Jan 12, 2013·Stroke; a Journal of Cerebral Circulation·Pamela M RistTobias Kurth
Jun 14, 2005·BMC Neurology·Magdy SelimGottfried Schlaug
Jan 16, 2008·CNS Drugs·Matthias W Riepe, Roman Huber
Nov 30, 2010·La Presse médicale·Y BéjotM Giroud
Jun 3, 2014·Journal of the Neurological Sciences·Jie YangChengdu Stroke Registry and Nanjing First Hospital Stroke Registry investigators
Aug 13, 2014·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Bum Joon KimSun U Kwon
Jun 20, 2012·Cerebrovascular Diseases·Nancy Futrell
Jan 5, 2016·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Yohei MimaYasushi Okada
Nov 19, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Nergiz AgayevaEthem Murat Arsava
Mar 1, 2011·Archives of Gerontology and Geriatrics·Giovanni ZulianiAntonio Cherubini
Sep 28, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Guo-Mei ShiNanjing First Hospital Stroke Registry Investigators
Apr 9, 2009·Journal of the Neurological Sciences·G TelmanD Yarnitsky
Apr 26, 2008·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Sandra PinedaBruce Ovbiagele
Sep 15, 2007·Journal of the Neurological Sciences·Bruce OvbiageleJeffrey L Saver
Sep 22, 2009·International Journal of Stroke : Official Journal of the International Stroke Society·D DowlatshahiInvestigators of the Registry of the Canadian Stroke Network
Oct 13, 2006·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Steven J ShookDerk W Krieger
Jan 3, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y BéjotM Giroud
May 25, 2005·Archives of Gerontology and Geriatrics·Emily LubartBeni Habot
Jun 3, 2004·Best Practice & Research. Clinical Haematology·Richard L Mueller
Apr 5, 2016·International Journal of Clinical Practice·J P BembenekA Czlonkowska
Apr 2, 2014·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Zilong HaoXueli Chang
Mar 19, 2015·British Journal of Clinical Pharmacology·Christopher A RajkumarAlbert Ferro
Jul 23, 2016·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Sarah NelsonNatalia S Rost
Aug 25, 2016·Frontiers in Aging Neuroscience·Ruiying QiuJialing Wu
Mar 13, 2018·European Heart Journal. Cardiovascular Pharmacotherapy·Morten WürtzHenrik Toft Sørensen
Sep 12, 2006·Journal of Thrombosis and Haemostasis : JTH·M PaciaroniS Biagini
Oct 20, 2012·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Yuan FangMing Liu
Aug 23, 2017·Neurological Research·Tieer YuBei Shao
Apr 30, 2017·Revista de salud pública·Octavio Martínez-BetancurLiliana Mayor-Agredo
Apr 5, 2020·Journal of Clinical Medicine·Adam WiśniewskiGrzegorz Kozera

Citations

Mar 1, 1992·Journal of the Neurological Sciences·R JosephK M Welch
Nov 1, 1990·Neurology·M I ChimowitzC A Sila
Jun 1, 1989·Archives of Neurology·L B GoldsteinJ N Davis
Feb 21, 1974·The New England Journal of Medicine·A C CarvalhoR S Lees
Jan 1, 1997·Journal of the Neurological Sciences·J De KeyserN De Klippel
Aug 1, 1997·Controlled Clinical Trials·H P AdamsK J Grimsman
Nov 18, 1997·Archives of Neurology·V KarepovA D Korczyn
Dec 3, 1999·Journal of the Neurological Sciences·A ChamorroA Ordinas

Related Concepts

Chondroitin Sulfate, Zinc Salt
Analgesics, Anti-Inflammatory
Platelet Inhibitors
Org 10172
Severity of Illness Index
Dermatan Sulfate
Acute Cerebrovascular Accidents
Zorprin
Cerebrovascular Accident
Danaparoid sodium

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.